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ABSTRACT 
 
Background: The golden standard is rigid laryngoscopy and tracheal intubation in airway management. Aim: To 
study efficacy in stress response prevention on laryngoscopy and intubation and to study hemodynamic parameters 
intraoperatively. Materials and Methods: This study was a prospective, randomised, double blinded study which 
was conducted .Results: In both the study groups had similar demographicpro file. During laryngoscopy and 
intubation, esmolol and labetalol showed rise in heart rate, systolic blood pressure and RPP, whereas the values for 
MAP and DBP was not statistically significant difference. Conclusion: Labetalol is more effective when compared 
to esmolol in attenuating the sympathomimetic effect of laryngoscopy and intubation in lower doses. 
Keywords: Attenuation, Intubation, Laryngoscopy. 
Introduction 
In airway management, the golden standard is rigid 
laryngoscopy and tracheal intubation, even though the 
new airway devices are available in recent years[1].The 
serious challenges posed by changes of hemodynamic 
conditions are cardiovascular diseases like 
hypertension, coronary artery disease, vascular 
aneurysms. In these patients, sudden changes of 
hemodynamics may lead to left ventricular failure and 
myocardial ischemia[2]. Intracranial tumors or cerebral 
hematomas with decreased intracranial compliance and 
increased intracranial pressure may collapse[3]. The 
reflex phenomenon of cardiovascular response to 
laryngoscopy and intubation with afferent stimuli 
carried by glossopharyngeal nerve. Norepinephrine 
causes elevation of blood pressure and epinephrine 
causes heart rate change[4].  
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The role of beta blockers with bradycardia, 
antihypertensive, antiarrythmic and antiischemic 
properties in preventing cardiovascular stress response 
to intubation[5].In patients with co-morbidities, these 
reflex changes of hemodynamicsare exaggerated and 
detrimental. To stop the pressor response, many 
pharmacological attempts were made. Opioids like 
sodium nitroprusside, fentanyl, alfentanil, 
nitroglycerine, calcium channel blockers like 
verapamil, diltiazem, adrenergic blockers like clonidine 
, volatile inhalational agents, lignocaine intravenously 
are widely used. In decreasing stress response, 
intravenous esmolol and labetalol given before 
operation has shown to be effective. Esmolol has a 
rapid onset, short duration of action and it is a cardio-
selective β1 blocker agent. In cardiac patients, it causes 
depressor effect on myocardium. In higher doses, 
Labetalol is an α and β blocker is useful in preventing 
perioperative undesirable events of cardiovascular thus, 
resulting in hypotension and bradycardia. This study is 
a prospective, randomized, double blinded, 
comparative study of low esmolol versus low labetalol 
and this study aimed to study efficacy in stress 
response prevention on laryngoscopy and intubation 
and to study hemodynamic parameters intraoperatively. 
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Materials and methods 
This study was a prospective, randomised, double 
blinded study which was conducted in patients 
undergoing elective surgeries under general 
anaesthesia. This study was conducted on 50 ASA I 
patients of either sex undergoing elective surgeries 
under general anaesthesia. ASA I and 2 patients of 
either sex between age group of 20-55 years were 
included in the study. The exclusion criteria was 
patients who had extremes of age, or who were 
asthmatic, COPD patients, baseline bradycardia, heart 
block or who were on beta blockers. Sequentially 
numbered opaque sealed envelope was used for 
blinding. Patients were divided into two groups namely  
group E (Esmolol) and Group L (Labetalol) 
respectively. Peripheral line was secured with 18 G 
veinflon after confirming nil per oral status and 
informed consent was taken from all patients. 
Intravenous fluid Ringers lactate was started. Blood 
pressure monitor, electrocardiography and pulse 
oximeter were connected. Group E received  0.5 mg/kg 
diluted with 0.9% saline to 10 ml intravenously 3 mins 
prior to intubation. Group L received 0.25 mg/kg 
diluted with 0.9% saline to 10 ml intravenously 3 mins 
prior to intubation. Another anaesthetist was also 
blinded to the study and the heart rate (HR), systolic 
blood pressure (SBP), diastolic blood pressure (DBP), 
mean arterial pressure (MAP), rate pressure product 
(RPP) was measured preinduction, at induction and at 
1,3,5,10 mins post induction. Statistical methods such 
as mean, standard deviation, paired students ‘t’test . 
<0.05 P value was considered significant and <0.01 p 
value was considered highly significant. 
Results 
Table 1: Demographic profile, duration of surgery, intubation time 
Parameters Group E(Mean±SD) Group L(Mean±SD) P value 
Age(Years) 32±5.9 32.5±4.28 0.7589 
Weight(Kg) 53.22±2.14 54.12±2.74 0.8741 
Height (cms) 160.99±2.22 160.88±1.49 0.7854 
Sex (M/F) 13/12 13/12 1 
Duration of surgery 94.21±8.64 mins 95.99±7.54 mins 0.8413 
Intubation time  10.45±1.44 secs 11±1.74 secs 0.6547 
P <0.05value was considered significant * 
All demographic parameters are insignificant on comparision between 2 groups. 
Table 2: Pulse rate 
Pulse rate Group E(min) Group L(min) P value 
Pre-induction 84.58±8.22 84.11±12.69 0.852 
At incubation 107.37±10.4 96.57±8.22 <0.001* 
Post intubation 
1 min 108.98±7.84 99.25±11.47 <0.001* 
3 mins 96.82±8.44 90.54±10.74 0.022* 
5 mins 92.47±11.64 84.57±10.88 0.014* 
10 mins 90.55±10.44 75.97±7.05 <0.001* 
P <0.05value was considered significant * 
Heart rate is significant difference at the time of intubation and also post intubation. 
Table 3: Systolic blood Pressure 
Systolic Blood Pressure Group E(min) Group L(min) P value 
Pre-induction 122.87±8.98 125.88±9.74 0.076 
At incubation 155.21±9.99 141.27±11.99 0.006* 
Post intubation 
1 min 157.11±12.77 140.04±6.57 <0.001* 
3 mins 136.21±13.87 124.87±14.89 0.002* 
5 mins 125.99±8.57 117.89±8.45 0.017* 
10 mins 120.88±4.89 111.66±0.69 0.004* 
P <0.05value was considered significant * 
Systolic blood pressure is significant difference at the time of intubation and also post intubation. 
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Table 3: Diastolic blood Pressure 
 
Diastolic Blood Pressure Group E(min) Group L(min) P value 
Pre-induction 78.17±5.71 80.79±4.98 0.247 
At incubation 99.58±5.87 101.45±1.87 0.524 
Post intubation 
1 min 95.24±2.54 96.04±3.55 0.217 
3 mins 86.54±4..89 88.88±1.47 0.196 
5 mins 83.56±47.65 83.98±8.88 0.013* 
10 mins 77.11±5.45 78.64±1.27 0.933 
P <0.05value was considered significant * 
Diastolic blood pressure is significant difference at 5 mins of post intubation. 
 
Table 4: Mean Arterial Pressure 
Mean Arterial Pressure Group E(min) Group L(min) P value 
Pre-induction 92.38±4.89 95.58±6.21 0.090 
At incubation 116.59±3.87 115.87±1.18 0.300 
Post intubation 
1 min 115.58±5.74 110.65±5.98 0.041 
3 mins 103.23±5.04 100.54±5.79 0.249 
5 mins 96.57±2.07 93.67±4.89 0.222 
10 mins 92.58±2.84 91.24±4.69 0.114 
P <0.05value was considered significant * 
Mean Arterial Pressure is not significant any of the periods. 
 
Table 5: Rate Pressure Product 
Rate Pressure Product Group E(min) Group L(min) P value 
Pre-induction 10150±1489 10428±1778 0.528 
At incubation 16528±1239 13694±2089 <0.001 
Post intubation 
1 min 17258±3158 13256±1489 <0.001 
3 mins 13798±2.141 11358±1787 0.005 
5 mins 11852±2147 10789±2014 0.001 
10 mins 11478±1897 8945±1789 <0.001 
P <0.05value was considered significant * 
Rate pressure product is significant in all periods of induction except in ppreinduction. 
Discussion 
In the present study, during laryngoscopy and 
intubation, esmolol and labetalol showed rise in heart 
rate, systolic blood pressure and Rate pressure product 
so Labetalol is more effective when compared to 
esmolol in attenuating the sympathomimetic effect of 
laryngoscopy and intubation in lower doses. Many 
studies conducted showed same as study done by 
Suruchi Ambasta et al;[6]it was observed that both the 
study groups had similar demographic profile. 
Statistical calculations were done by Instatversion3.10. 
The study data were analyzed using statistical methods 
of mean, standard deviation. Esmolol (0.5mg/kg), 
labetalol (0.25mg/kg) significantly attenuated the rise 
in heart rate, systolic blood pressure, and RPP during  
 
laryngoscopy and intubation. However, the difference 
was not statistically significant among the values for 
DBP and MAP. B.Sowbhagya Lakshmi et al;[7] 
observed that esmolol and  labetalol   significantly  
attenuated   HR,  SBP,  DBP  during laryngoscopy and 
intubation ,compared  to  placebo. Dr. Arti Rathore et 
al;[8]carried out a study on100healthy adult 
patients(ASA I and II) undergoing elective surgery 
under general anaesthesia. The patients were randomly 
allocated into 4groups of 25 each i.e. A(control),B,C 
and D receiving ,50mgs,100mgs, 150mgs of esmolol 
hydrochloride intravenously 2 minutes before 
intubation. The pulserate, systolic blood pressure, ECG 
were recorded continuously after giving preanaesthetic 
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medication till seven minutes after intubation. The study 
showed that all the doses were effective in blunting the 
pulse rate response but only the150 mgs proved effective 
significantly in blunting the blood pressure response. 
The rate pressure product, a measure of cardiac 
consumption was also found to be significantly lower 
in groups C, D.Bon Sebastian et al;[9]observed that 
groups were well matched for their demographic data. 
There was a statistically significant difference (P< 
0.05) between dexmedetomidine and normal saline in 
heart rate, systolic, diastolic and mean arterial 
pressures at all time points after tracheal intubation 
with dexmedetomidine 0.75 μg/kg being most 
effective. Sedation scores were more with 
dexmedetomidine. None of the patients had any 
adverse effects such as hypotension, bradycardia, 
respiratory depression and fall in oxygen saturation. 
Sulaiman S et al;[10]observed that the 
dexmedetomidine group had a better control of 
hemodynamics during laryngoscopy and endotracheal 
intubation. Dexmedetomidine at a dose of 0.5 mcg/kg 
as 10-min infusion was administered prior to induction 
of general anaesthesia attenuates the sympathetic 
response to laryngoscopy and intubation in patients 
undergoing myocardial revascularization. Koju RB et 
al;[11] observed that there was an increase in systolic 
blood pressure, diastolic blood pressure, heart rate were 
significantly lower (p<0.05) in esmol group when 
compared to lidocaine and placebo group but there was 
no statistical significance (P>0.05) between control and 
lidocaine group after laryngoscopy and intubation. 
Conclusion 
 Labetalol is more effective when compared to esmolol 
in attenuating the sympathomimetic effect of 
laryngoscopy and intubation in lower doses.  
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